Secor Capital Advisors’s Insmed INSM Stock Holding History

Secor Capital Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-22,607	Closed	-$535K	–	491
2018 Q2	$535K	Buy	22,607 +5,958	+36%	+$153K	0.05%	376
2018 Q1	$375K	Buy	+16,649	New	+$438K	0.03%	404
2017 Q3	–	Sell	-23,781	Closed	-$408K	–	488
2017 Q2	$408K	Buy	+23,781	New	+$406K	0.04%	370
2016 Q3	–	Sell	-82,799	Closed	-$816K	–	586
2016 Q2	$816K	Buy	+82,799	New	+$966K	0.1%	280
2015 Q4	–	Sell	-11,512	Closed	-$214K	–	579
2015 Q3	$214K	Sell	11,512 -5,515	-32%	-$138K	0.07%	433
2015 Q2	$416K	Buy	+17,027	New	+$387K	0.15%	249
2014 Q4	–	Sell	-12,195	Closed	-$159K	–	417
2014 Q3	$159K	Buy	+12,195	New	+$184K	0.09%	292

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Secor Capital Advisors's INSM Position: Q3 2018 in Review

Secor Capital Advisors sold out of Insmed (INSM) in Q3 2018, closing a stake of 22,607 shares — an estimated $535K sold.

Secor Capital Advisors first reported a position in INSM in Q3 2014 and held it in 7 quarters. The position peaked at $816K in Q2 2016. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

Secor Capital Advisors reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
Secor Capital Advisors sold 22,607 Insmed shares in Q3 2018, an estimated $535K.
Secor Capital Advisors first reported a position in Insmed in Q3 2014 and held it in 7 quarters.
Secor Capital Advisors's Insmed position peaked at $816K in Q2 2016.
123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.